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OBJECTIVES: Production of carcinogenic acetaldehyde
by Candida has been suggested to contribute to epithelial
dysplasia and oral carcinogenesis. Oral lichen planus
(OLP), oral lichenoid lesion (OLL) and oral leukoplakia
(OL) are potentially carcinogenic oral diseases where
colonisation by Candida is common, but acetaldehyde
production by Candida has not been studied.
STUDY DESIGN: Acetaldehyde production in ethanol
(11 mM), glucose (100 mM), ethanol–glucose (11 mM
and 100 mM) or red wine (1200 mM ethanol) incubation
by Candida albicans from patients with OLL (n = 6), OLP
(n = 16), OL (n = 6) and controls (n = 6) was measured
by gas chromatography. Participants completed a ques-
tionnaire regarding their smoking habits and alcohol
consumption.
RESULTS: All Candida albicans isolates produced poten-
tially carcinogenic levels of acetaldehyde (>100 lM) in all
incubations containing ethanol. The control group iso-
lates produced the highest acetaldehyde levels. Isolates
from smokers produced more acetaldehyde in all incu-
bations than those from non-smokers. The difference was
significant in ethanol–glucose incubation. Isolates from
patients who were both smokers and drinkers produced
the highest amounts when incubated in ethanol, ethanol–
glucose and wine.
CONCLUSIONS: Candida albicans isolated from poten-
tially carcinogenic oral diseases can produce mutagenic
amounts of acetaldehyde. Cigarette smoking and alcohol
consumption may favour adaptational changes resulting
in the upregulation of candidal acetaldehyde metabolism.
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Introduction
Oral lichen planus (OLP), oral lichenoid lesion (OLL) and
oral leukoplakia (OL) are classiﬁed as potentially carcino-
genic conditions or lesions (1). Various factors such as
immune dysregulation, alcohol consumption and smoking
have been identiﬁed in their etiopathogenesis (1–4). It has
also been suggested that colonisation by Candida albicans
may contribute to this as patients with these oral conditions
and lesions often suffer from recurrent candidal infections
(1, 5, 6). However, this may also be secondary to the
underlying immunological dysregulation or to the use of
immunosuppressive medications in the treatment (7). The
prevalence of malignant transformation in OLP and OLL
patients has been reported to be roughly 2% in 5-year
follow-up, and this transformation does not appear to be
restricted to the site of the lesion (1, 8, 9).
Alcohol consumption and tobacco smoking have an
important role in oral carcinogenesis (10–13). It has recently
been shown that 44% of upper aerodigestive tract cancers in
men in Europe and 25% in women may be attributable to
alcohol consumption (14). In the human body, ethanol
becomes oxidised into acetaldehyde that is a highly reactive
and toxic compound recently reclassiﬁed as a Group 1
carcinogen by the International Agency for Research on
Cancer (12, 15). Acetaldehyde binds directly to DNA and
may cause mutations at concentrations as low as 100 lM
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(16–19). After moderate alcohol intake, marked levels of
acetaldehyde can be detected in saliva for prolonged periods
(20, 21). The oral microbiota has been shown to have a role
in the salivary acetaldehyde production (20, 22, 23).
Candida species have proved to have an extraordinary
capacity to produce acetaldehyde from ethanol by oxidation
as well as from glucose by fermentation (24, 25). High
levels of acetaldehyde can also be detected in tobacco
smoke (26).
Alcoholic beverages often contain acetaldehyde as a
congener (18). During the process of alcohol fermentation,
high amounts of acetaldehyde become produced from the
various carbon sources (27). The concentration of acetalde-
hyde in wine is subject to the production process as well as
the concentration of glucose and fructose and other
constituents present in wine and produced during fermen-
tation (18, 27, 28). Wine and other alcoholic beverages
produced by fermentation and containing rather high
concentrations of ethanol may contain more acetaldehyde
than those beverages produced by distillation as highly
volatile acetaldehyde escapes during the production process
(18).
The role of candidal acetaldehyde production in poten-
tially malignant oral disorders is unknown. Therefore, the
aim of this study was ﬁrstly to examine the ability of
Candida albicans isolated from various potentially malig-
nant lesions to produce carcinogenic levels of acetaldehyde.
Our hypothesis was that candidal acetaldehyde production
may have a role in the malignant transformation of these
lesions. Secondly, we wanted to analyse whether alcohol
consumption and smoking habits of the patients have an
impact on the candidal acetaldehyde metabolism. Regular
alcohol consumption and smoking may lead to adaptation of




A total of 28 patients referred to the Clinic of Oral Medicine
Unit of the University of the Basque Country, Spain, during
2007–2010 with potentially malignant oral disorders and
positive for Candida albicans by culture were included in
the study (Table 1). Clinical assessment followed the
standardised protocol by the Spanish Society of Oral
Medicine (SEMO), and the clinicopathological diagnostic
criteria of oral lichenoid disease (OLD; n = 22) (29) and
oral leukoplakia (OL; n = 6) (3). The patients with OLD
were further classiﬁed as oral lichenoid lesion (OLL; n = 6)
or oral lichen planus (OLP; n = 16) following the criteria of
van der Meij and van der Waal (30). Patients with recent or
ongoing antifungal or steroid therapy were excluded from
the study. Six patients with healthy oral mucosa but positive
for Candida albicans by culture attending the Dental Clinic
Service were recruited as controls. One isolate per study
subject was included. All participants completed a ques-
tionnaire regarding their smoking habits and alcohol
consumption and were stratiﬁed into smokers or non-
smokers and drinkers or non-drinkers for the analyses. One
cigarette or cigar was scored as one unit of tobacco, and
one glass of wine (150 ml), one bottle of beer (330 ml) or
one measure of spirit (35 ml) was scored as one unit of
alcohol (31). The protocol was approved by the Ethics
Committee (CEISH) of the University of the Basque
Country/EHU, and each subject in the project signed a
detailed informed consent form.
Candida albicans isolates
Candida albicans were isolated from patient samples using
conventional culture methods and stored in the departmental
culture collection at 80°C. Identiﬁcation was based on
colony morphology, growth on chromogenic agar (CHRO-
Magar Candida, France), microscopy and biochemical
reactions in API ID32C (Bio-Merieux, Marcy L‘Etoile,
France) assimilation tests. Identiﬁcation was conﬁrmed by
molecular methods using PCR primers CR-r and CR-f as
described earlier (32).
Acetaldehyde measurement
The method previously described by Nieminen et al. (24)
was used for the measurement acetaldehyde production by
Candida. C. albicans isolates were ﬁrst incubated on
Sabouraud agar (Oxoid, UK) at 37°C for 48 h prior to the
experiment. Colonies of each isolate were suspended into
phosphate buffered saline (PBS) and adjusted to a ﬁnal
concentration of 1 9 107 colony-forming units per milli-
litre (CFU/ml) by haemocytometer. A yeast suspension of
500 ll was transferred into vials containing 500 ll of
ethanol (EtOH; ﬁnal concentration of 11 mM) or glucose
(ﬁnal concentration of 100 mM) or ethanol and
glucose (ﬁnal concentration of 11 mM EtOH and
100 mM glucose) or red wine including 14.0% v/v
ethanol (ﬁnal concentration of 1200 mM EtOH,) (Mar-
qués del Norte, La Rioja, Spain). The samples were
sealed with silicon caps and incubated at 37°C for
30 min. The reaction was stopped by injecting 100 ll of
perchloric acid (PCA; ﬁnal concentration of 0.6 M).
Three parallel samples were processed, and the experi-
ment was repeated once. To measure the baseline and
artefactual acetaldehyde, 100 ll of PCA was added
immediately to control vials that contained yeast cells
only, and the suspension was incubated for 30 min at
37°C. The formed ACH was measured by gas chroma-
tography using the Varian CP-3800 equipped with a
Zebron ZB-WaxPlus (Phenomenex Inc., Torrance, CA,
USA) column and detection by ﬂame ionisation (FID) and
with automated CombiPal Headspace sampler (Agilent
Technologies, Mississagua, ON, Canada) and subtracted
from the initial values as reported earlier (24).
Statistical analyses
The results are expressed as means (±SEM). The data were
analysed using SPSS statistical package 18.0 (SPSS Inc.,
Chicago, IL, USA). The generalised estimating equations
model (GEE) was used for comparisons between species
and experimental conditions, and for the analyses of
correlations. Comparisons were made for groups with
n  3. Patients who were both drinkers and smokers were
excluded from the comparisons owing to small numbers.
The correlation was expressed with a 95% conﬁdence
interval. A P‐value < 0.05 was considered statistically
signiﬁcant.
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All Candida albicans isolates produced high levels of
acetaldehyde (>100 lM) in all incubations containing etha-
nol. The mean acetaldehyde production was 190.3 lM
(±3.2 lM) in 11 mM ethanol, 229.7 lM (±3.5 lM) in
ethanol–glucose (11 mM and 100 mM, respectively), and
111.7 lM(±3.4 lM) inwine incubation (1200 mMethanol).
However, in 100 mM glucose incubation, the mean acetal-
dehyde production was low (42.3 ± 1.3 lM). The isolates
from smokers (n = 9) produced more acetaldehyde than the
non-smoker (n = 22) isolates in all incubations (Table 2).
This difference was statistically signiﬁcant in ethanol–
glucose incubation (P = 0.020). The alcohol drinker isolates
(n = 8) produced more acetaldehyde than the non-drinker
isolates (n = 23) in wine incubation, but the difference was
not signiﬁcant. The isolates from patients who were both
smokers and drinkers (n = 3) produced the highest amounts
of acetaldehyde of all subgroups in ethanol (mean
226.6 ± 7.8 lM), ethanol–glucose (260.5 ± 6.5 lM) and
wine (125.8 ± 8.6 lM; P = 0.008, P < 0.001, P = 0.024,
respectively).
Interestingly, isolates from the control group produced
more acetaldehyde than the isolates from the other groups in
ethanol (mean, 215.5 ± 9.6 lM) and ethanol–glucose
(260.2 ± 8.4 lM) incubations (Fig. 1a,b). The production
was signiﬁcantly higher than that of the OLL isolates when
exposed to ethanol (P = 0.011), ethanol and glucose
(P < 0.001) or glucose alone (P = 0.032). However, the
levels produced by the OLP and OL isolates were not
signiﬁcantly lower than those produced by the control
isolates in ethanol–glucose, glucose or wine. In 100 mM
glucose, the acetaldehyde production was low in all
clinical groups (Fig. 1c). When exposed to wine, OLL
isolates produced the highest levels of acetaldehyde
(124.4 ± 7.7 lM) (P = ns, Fig. 1d). There was no signif-
icant difference in acetaldehyde production by isolates from
patients with or without erosive OLD lesions in any of the
incubations.
The proportion of smokers in the OLL and OLP groups
was similar to that of the control group, whereas all patients
in the OL group were smokers. The proportion of drinkers
in the OLL and OLP groups was similar to that of the OL
group, whereas the majority of patients in the control group
reported regular alcohol consumption (Table 1).
When incubated in wine, the isolates from smokers with
OLL, OLP or OL produced more acetaldehyde than the
control isolates (172.3 ± 13.3 lM, 124.8 ± 9.1 lM and
Table 1 Patient characteristics of Candida albicans isolates used in the study







OLL1 54 F Reticular only No Asymmetrical Histopathology <10 U/day No
OLL2 74 F Reticular only No Asymmetrical No 14 U/week
OLL3 65 M Reticular + plaque No Asymmetrical No No
OLL4 81 F Reticular + plaque No Asymmetrical Histopathology No No
OLL5 49 M Reticular + atrophic No Asymmetrical No 49 U/week
OLL6 76 F Reticular + atrophic No Asymmetrical Histopathology No No
OLP1 40 F Reticular only No Symmetrical <10 U/day No
OLP2 42 F Reticular only No Symmetrical No No
OLP3 49 M Reticular only No Symmetrical No No
OLP4 63 F Reticular only No Symmetrical No No
OLP5 53 M Reticular + atrophic Yes Symmetrical Skin manifestations No 7 U/week
OLP6 56 M Reticular + plaque No Symmetrical No 56 U/week
OLP7 76 F Reticular + atrophic Yes Symmetrical Skin manifestations No No
OLP8 76 F Reticular + atrophic Yes Symmetrical <10 U/day No
OLP9 57 M Reticular only No Symmetrical Histopathology, skin
manifestations
No No
OLP10 58 M Reticular only No Symmetrical Histopathology No No
OLP11 59 F Reticular only No Symmetrical Histopathology No No
OLP12 36 M Reticular + plaque No Symmetrical Histopathology >10 U/day No
OLP13 55 F Reticular + atrophic Yes Symmetrical Histopathology No No
OLP14 57 F Reticular + atrophic Yes Symmetrical Histopathology No 7 U/week
OLP15 83 F Reticular + atrophic Yes Symmetrical Histopathology No No
OLP16 74 F Reticular + plaque + atrophic Yes Symmetrical Histopathology No No
OL1 46 F Homogeneous No Histopathology >10 U/day No
OL2 57 M Homogeneous No Histopathology >10 U/day 7 U/week
OL3 60 F Homogeneous No Histopathology >10 U/day No
OL4 74 F Homogeneous No Histopathology >10 U/day No
OL5 80 F Homogeneous No Histopathology >10 U/day No
OL6 64 M Non-homogeneous speckled (20) No Histopathology >10 U/day 28 U/week
C1 21 F – – – – No 2 U/week
C2 34 M – – – – >10 U/day No
C3 50 M – – – – No 10 U/week
C4 54 F – – – – No 2 U/week
C5 59 F – – – – No No
C6 59 F – – – – >10 U/day 3 U/week
OLL, Oral lichenoid lesions (n = 6); OLP, Oral lichen planus (n = 16); OL, Oral leukoplakia (n = 6); C, Control patients (n = 6); U/day, units per day; U/
week, units per week.
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119.0 ± 8.5 lM, respectively). The isolates from smokers
of the OLL group produced the highest levels of acetalde-
hyde (172.3 ± 13.3 lM). When incubated in ethanol–
glucose, a similar trend in the acetaldehyde production
could be seen: isolates from smoker patients with OLD
produced signiﬁcantly more acetaldehyde than non-smoker
isolates (P = 0.035). When incubated in ethanol alone, the
smoker isolates of the OLL, OLP and OL groups produced
less acetaldehyde than control isolates (139.5 ± 9.1 lM,
221.2 ± 10.1 lM and 175.4 ± 11.1 lM, accordingly). In
glucose incubation, the isolates from smokers with OL
produced more acetaldehyde than the control isolates
(59.0 ± 4.8 lM vs. 44.7 ± 5.4 lM).
Isolates from the OLP and control group patients who
reported regular alcohol consumption produced higher
amounts of acetaldehyde in wine incubation than those
from non-drinkers within the same group (106.0 ± 11.7 lM
vs. 101.3 ± 5.0 lM, 143.6 ± 13.0 lM vs. 65.8 ± 13.4 lM,
accordingly). Surprisingly, in the OLL group, isolates from
non-drinkers produced higher amounts of acetaldehyde than
the isolates from drinkers when incubated in wine
(136.9 ± 9.7 lM and 99.4 ± 9.4 lM, accordingly). In
ethanol–glucose incubation, the OLP drinker isolates pro-
duced the highest levels of acetaldehyde in ethanol–glucose
incubation (230.2 ± 8.2 lM). When incubated in ethanol
alone, the OLD non-drinker isolates produced more acetal-
dehyde than the drinker isolates (187.6 ± 4.1 lM vs.
173.8 ± 5.0 lM, P = ns). When incubated in glucose
alone, the drinker isolates of the control group were the
highest producers of acetaldehyde (42.5 ± 4.5 lM).
Discussion
Candida albicans is part of oral microbiota in most healthy
individuals (33, 34). Presence of yeasts in the oral cavity has
also been linked to epithelial dysplasia and oral carcino-
genesis (6, 35, 36). A number of Candida spp. is known to
be able to produce carcinogenic levels of acetaldehyde in
the presence of ethanol (24, 27). Levels above 100 lM have
been reported to be able to form DNA adducts, DNA cross-
links, sister chromatid changes and chromosomal aberra-
tions (16). Acetaldehyde has also been shown to interfere
with DNA repair mechanisms including inducing mutations
in the p53 tumour suppressor gene (19). In the present
study, C. albicans isolated from patients with potentially




Figure 1 Mean acetaldehyde production by Candida albicans isolates from four different clinical groups oral lichenoid lesion (n = 6), oral lichen planus
(n = 12), OL (n = 6) and controls (n = 6). The isolates were incubated in 11 mM ethanol (A), 11 mM ethanol and 100 mM glucose (B), 100 mM glucose
(c), red wine (1200 mM ethanol ﬁnal concentration) (d). The isolates were incubated at 37°C for 30 min. Error bars represent the standard error of mean
(±SEM) within groups. Signiﬁcant differences marked (***P < 0.001, **0.001 < P < 0.05).
Table 2 Mean acetaldehyde production (±SEM) by Candida albicans
isolates from smokers and non-smokers (a) and regular alcohol consumers
(drinkers) and non-drinkers (b)
(a) Non-smokers (n = 22) Smokers (n = 9) P
Ethanol 184.3 ± 3.6 193.0 ± 7.3 0.601
Ethanol–glucose 215.9 ± 3.8 253.2 ± 7.4 0.020**
Glucose 40.3 ± 1.5 46.9 ± 2.8 0.320
Wine 104.4 ± 4.3 124.8 ± 5.8 0.107
(b) Non-drinkers (n = 23) Drinkers (n = 8) P
Ethanol 187.2 ± 3.7 185.8 ± 7.4 0.922
Ethanol–glucose 232.0 ± 4.2 211.7 ± 7.1 0.226
Glucose 44.2 ± 1.6 36.5 ± 2.2 0.172
Wine 107.5 ± 4.1 118.5 ± 7.4 0.501
Signiﬁcant differences marked (** 0.001 < P < 0.05).
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levels of acetaldehyde in the presence of clinically relevant
concentrations of ethanol, ethanol and glucose, and red wine
(17). The concentrations of ethanol used in the present study
can be found in blood and saliva after moderate alcohol
consumption, and concentrations of glucose used in normal
food and drinks (24). Although levels of acetaldehyde
formed in glucose incubation were low, co-incubation with
ethanol resulted in higher levels than in ethanol alone.
Acetaldehyde production was slightly lower in wine than in
the other ethanol-containing incubations. This is likely due
to the high level of ethanol being toxic to Candida and the
very low concentration of residual sugar as an alternative
source of carbon in wine (37).
Interestingly, isolates of C. albicans from patients who
reported to be smokers produced more acetaldehyde in all
incubations than the isolates from non-smokers. The
difference was signiﬁcant in ethanol–glucose incubation.
In wine, smoker isolates from all clinical groups produced
more acetaldehyde than corresponding non-smoker isolates.
Increased candidal acetaldehyde metabolism in smokers
may in part explain the results of previous studies where
high salivary acetaldehyde levels in heavy smokers were
reported independently of their own ethanol metabolism
(20, 38, 39). It is possible that Candida colonising the oral
surfaces and repeatedly exposed to acetaldehyde in cigarette
smoke becomes more tolerant to acetaldehyde and decreases
its downstream metabolism via the citric acid cycle. It is
also possible that acetaldehyde or the various other toxic
agents in cigarette smoke provoke a general stress response
in the candidal cells resulting in upregulation of anaerobic
acetaldehyde-ethanol metabolism. These changes may be
translational or the results of microevolution and selection.
In our set of isolates, the likely explanations are genetic
changes as the isolates were passaged multiple times in the
absence of exposure to cigarette smoke before used in the
experiments. Further studies are needed to address this
point.
Isolates from patients who reported regular alcohol
consumption produced higher acetaldehyde levels than
isolates from non-drinkers, in ethanol, ethanol–glucose
and glucose incubations. However, the differences between
drinker and non-drinker isolates were statistically signiﬁcant
only in the control group. It is well known that most people
under-report their alcohol consumption in non-anonymised
questionnaires and self-reporting is highly unreliable (40,
41). Furthermore, smoking and alcohol consumption may
have a cumulative effect on candidal acetaldehyde metab-
olism as isolates from patients who were both smokers and
drinkers produced the highest amounts of acetaldehyde in
ethanol, ethanol–glucose and wine. This is in accordance
with previous work where smoking and alcohol consump-
tion have been shown to have a synergistic effect on salivary
acetaldehyde levels in vivo (39, 42). In most countries, high
alcohol consumption and smoking have been more
prevalent in men than in women, which is in line with the
higher overall prevalence of aerodigestive tract cancers as
well as with the higher prevalence of cancers potentially
attributable to alcohol consumption in men (14). However,
it is not known what proportion of those patients who
develop oral cancer have had potentially malignant oral
lesions and Candida colonisation. Nevertheless, as alcohol
consumption increases, the role of candidal acetaldehyde
production in the malignant transformation of OLD may
increase.
Oral leukoplakia has been reported with a higher risk of
malignant transformation than oral lichenoid disorder
lesions (1). This has been linked to a higher exposure to
other risk factors such as alcohol and tobacco in this
patient group (1, 3). In our study, the isolates from the OL
group produced signiﬁcantly higher levels of acetaldehyde
than isolates from oral lichenoid disorders when exposed
to ethanol–glucose or glucose alone. In OL, high incidence
of colonisation by Candida, high incidence of smoking
and increased candidal acetaldehyde metabolism may all
cumulatively contribute to the malignant transformation.
The malignant potential of oral lichenoid disorders is
controversial, and it has been suggested that this potential
would be higher in OLL than in OLP lesions (9). In our
study, although isolates from both lichenoid disorder
groups produced carcinogenic levels of acetaldehyde,
OLP isolates produced higher levels than isolates of the
OLL group.
In conclusion, our in vitro study shows that Candida
albicans isolated frompotentiallymalignant oral disorders are
able to produce mutagenic amounts of carcinogenic acetalde-
hyde when exposed to substrates such as wine and ethanol.
Acetaldehyde produced locally byCandidamay contribute to
the pathogenesis of these oral disorders and to their malignant
transformation. Oral cancer is a multifactorial disease and, in
general, accumulation of risk factors is required for the
malignant transformation. Chronic candidal infection result-
ing in local production of a carcinogen can alone explain some
cases of oral cancer in patients with no other risk factors, and it
certainly can contribute to the higher incidence of cancer in
patients with potentially malignant oral mucosal diseases.
Cigarette smoking and alcohol consumption may favour
adaptational changes resulting in upregulation of candidal
acetaldehyde metabolism. However, a spectrum of other
factors may affect the metabolic activity of Candida on oral
surfaces in vivo, whereby further studies in a more complex
setting resembling invivoconditionsarewarranted toelucidate
the effects of candidal acetaldehyde production on mucosal
cells.
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